A synonymous germline variant PALB2 c.18G>T (p.Gly6=) disrupts normal splicing in a family with pancreatic and breast cancers.
Ciyu YangOzge Ceyhan-BirsoyDiana MandelkerSowmya JairamAmanda CatchingsEileen M O'ReillyMichael F WalshZarina YelskayaPublished in: Breast cancer research and treatment (2018)
Our results indicate that the PALB2 c.18G>T (p.Gly6=) variant is likely pathogenic. This study provided important laboratory evidence for classification of this variant and guided improved patient management.